2020
DOI: 10.1097/rmr.0000000000000234
|View full text |Cite
|
Sign up to set email alerts
|

Adult Glioma WHO Classification Update, Genomics, and Imaging

Abstract: Recent advances in the understanding of the genetic makeup of gliomas have led to a paradigm shift in the diagnosis and classification of these tumors. Driven by these changes, the World Health Organization (WHO) introduced an update to its classification system of central nervous system (CNS) tumors in 2016. The updated glioma classification system incorporates molecular markers into tumor subgrouping, which has been shown to better correlate with tumor biology and behavior as well as patient prognosis than t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
46
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 50 publications
(46 citation statements)
references
References 54 publications
0
46
0
Order By: Relevance
“…Glioma is one of the most common primary brain tumor, with an annual incidence of 3–8 per 100,000 population ( 1 ). As the most malignant subtype of glioma, glioblastoma multiforme (GBM) have an around 14 months of median survival ( 2 , 3 ). Despite the availability of conventional treatments, such as surgical resection, adjuvant radiotherapy, and chemotherapy, the effects of prolonged survivals in GBM patients were still limited ( 4 ).…”
Section: Introductionmentioning
confidence: 99%
“…Glioma is one of the most common primary brain tumor, with an annual incidence of 3–8 per 100,000 population ( 1 ). As the most malignant subtype of glioma, glioblastoma multiforme (GBM) have an around 14 months of median survival ( 2 , 3 ). Despite the availability of conventional treatments, such as surgical resection, adjuvant radiotherapy, and chemotherapy, the effects of prolonged survivals in GBM patients were still limited ( 4 ).…”
Section: Introductionmentioning
confidence: 99%
“…Glioma is a common and lethal primary malignant central nervous system tumor with a poor prognosis. It accounts for 30% of all brain tumors and central nervous system tumors and 80% of all malignant brain tumors [ 1 ]. The median survival time of patients with glioma is about 20 to 36 months, and the survival time of patients with glioblastoma (GBM) is less than 14 months [ 2 ].…”
Section: Introductionmentioning
confidence: 99%
“…Here we consider an application of quasi-diffusion imaging to a high-grade glial tumour, the glioblastoma multiforme (GBM). Clinical assessment of glial tumour grade and genetic subtype is relevant for predicting patient survival time and treatment strategy which includes surgical resection, chemo-and radiotherapy, and the need for accurate delineation of tumour tissue boundaries [68,69].…”
Section: Quasi-diffusion Imaging Of Brain Tumourmentioning
confidence: 99%